Crohn’s Disease Study involving an investigational subcutaneous medication (PF-04236921)). Double-blind, placebo-controlled study.
Details of Research
Contact: Shelley Mikolainis, Study Coordinator
E-mail: smikolainis@mtsinai.on.ca
Details of Research
Contact: Shelley Mikolainis, Study Coordinator
E-mail: smikolainis@mtsinai.on.ca